CYP 1.89% 27.0¢ cynata therapeutics limited

Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-172

  1. 4,081 Posts.
    lightbulb Created with Sketch. 1387
    Hi @pfeifer1982,

    What are your thoughts on the latest update, regarding our MEND trial.
    This was updated on the 20th July 2022.

    This stood out to me and just wondering, what to make of it.

    https://hotcopper.com.au/data/attachments/4536/4536844-efdee2a233b6be08ce3998ff27892801.jpg

    https://clinicaltrials.gov/ct2/history/NCT04537351?A=1&B=5&C=Side-by-Side#StudyPageTop

    Thanks in advance.

    Regards

    Rossi70
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.